scholarly journals Dupilumab efficacy and safety in Japanese patients with uncontrolled, moderate-to-severe asthma in the phase 3 LIBERTY ASTHMA QUEST study

2020 ◽  
Vol 69 (4) ◽  
pp. 578-587
Author(s):  
Yuji Tohda ◽  
Yoichi Nakamura ◽  
Takao Fujisawa ◽  
Motohiro Ebisawa ◽  
Kazuhiko Arima ◽  
...  
Keyword(s):  
Severe Asthma ◽  
Japanese Patients ◽  
Efficacy And Safety ◽  
Phase 3

scholarly journals Efficacy and safety of baricitinib in Japanese patients with rheumatoid arthritis: Subgroup analyses of four multinational phase 3 randomized trials

2017 ◽  
Vol 28 (4) ◽  
pp. 583-591 ◽  
Author(s):  
Yoshiya Tanaka ◽  
Tatsuya Atsumi ◽  
Koichi Amano ◽  
Masayoshi Harigai ◽  
Taeko Ishii ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Randomized Trials ◽  
Japanese Patients ◽  
Efficacy And Safety ◽  
Phase 3 ◽  
Subgroup Analyses

scholarly journals Efficacy and safety of secukinumab in Japanese patients with active ankylosing spondylitis: 24-week results from an open-label phase 3 study (MEASURE 2-J)

2019 ◽  
Vol 30 (1) ◽  
pp. 132-140 ◽  
Author(s):  
Mitsumasa Kishimoto ◽  
Atsuo Taniguchi ◽  
Ayako Fujishige ◽  
Shuhei Kaneko ◽  
Sibylle Haemmerle ◽  
...  
Keyword(s):  
Ankylosing Spondylitis ◽  
Japanese Patients ◽  
Efficacy And Safety ◽  
Open Label ◽  
Phase 3 ◽  
Open Label Phase

scholarly journals Efficacy and safety of sofosbuvir–velpatasvir with or without ribavirin in HCV-infected Japanese patients with decompensated cirrhosis: an open-label phase 3 trial

2018 ◽  
Vol 54 (1) ◽  
pp. 87-95 ◽  
Author(s):  
Tetsuo Takehara ◽  
Naoya Sakamoto ◽  
Shuhei Nishiguchi ◽  
Fusao Ikeda ◽  
Tomohide Tatsumi ◽  
...  
Keyword(s):  
Japanese Patients ◽  
Decompensated Cirrhosis ◽  
Efficacy And Safety ◽  
Open Label ◽  
Phase 3 ◽  
Open Label Phase
Sign in / Sign up

Export Citation Format

Share Document